Shenzhen Neptunus Interlong Bio-Technique Co (HKSE:08329) Days Sales Outstanding : 0.00 (As of Dec. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Shenzhen Neptunus Interlong Bio-Technique Co Days Sales Outstanding?

Shenzhen Neptunus Interlong Bio-Technique Co's average Accounts Receivable for the three months ended in Dec. 2024 was HK$181.7 Mil. Shenzhen Neptunus Interlong Bio-Technique Co's Revenue for the three months ended in Dec. 2024 was HK$0.0 Mil.

The historical rank and industry rank for Shenzhen Neptunus Interlong Bio-Technique Co's Days Sales Outstanding or its related term are showing as below:

HKSE:08329' s Days Sales Outstanding Range Over the Past 10 Years
Min: 43.26 Med: 62.66 Max: 122.21
Current: 122.21

During the past 13 years, Shenzhen Neptunus Interlong Bio-Technique Co's highest Days Sales Outstanding was 122.21. The lowest was 43.26. And the median was 62.66.

HKSE:08329's Days Sales Outstanding is ranked worse than
81.5% of 957 companies
in the Drug Manufacturers industry
Industry Median: 72.09 vs HKSE:08329: 122.21

Shenzhen Neptunus Interlong Bio-Technique Co's Days Sales Outstanding declined from Jun. 2023 (68.05) to Dec. 2024 (0.00).

Shenzhen Neptunus Interlong Bio-Technique Co Days Sales Outstanding Historical Data

The historical data trend for Shenzhen Neptunus Interlong Bio-Technique Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Neptunus Interlong Bio-Technique Co Days Sales Outstanding Chart

Shenzhen Neptunus Interlong Bio-Technique Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Sales Outstanding

Get a 7-Day Free Trial

43.26

50.41

87.35

89.70

59.22

Shenzhen Neptunus Interlong Bio-Technique Co Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Jun24	Dec24
Days Sales Outstanding	Get a 7-Day Free Trial															68.05	66.32	65.79	-	-

Competitive Comparison of Shenzhen Neptunus Interlong Bio-Technique Co's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Shenzhen Neptunus Interlong Bio-Technique Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shenzhen Neptunus Interlong Bio-Technique Co's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shenzhen Neptunus Interlong Bio-Technique Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Shenzhen Neptunus Interlong Bio-Technique Co's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

Shenzhen Neptunus Interlong Bio-Technique Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Shenzhen Neptunus Interlong Bio-Technique Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

	Days Sales Outstanding (A: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (190.593	+	170.325)	/	2 )	/	1112.192	*	365
=	180.459					/	1112.192	*	365
=	59.22

Shenzhen Neptunus Interlong Bio-Technique Co's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding (Q: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2024 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (193.012	+	170.325)	/	2 )	/	0	*	365 / 4
=	181.6685					/	0	*	365 / 4
=	N/A

Shenzhen Neptunus Interlong Bio-Technique Co (HKSE:08329) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Shenzhen Neptunus Interlong Bio-Technique Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Shenzhen Neptunus Interlong Bio-Technique Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Shenzhen Neptunus Interlong Bio-Technique Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Neptunus Interlong Bio-Technique Co Ltd (HKSE:08329) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

N/A

Address

979 King’s Road, 43rd Floor, One Taikoo Place, Quarry Bay, Hong Kong, HKG

Website

https://www.interlong.com

Shenzhen Neptunus Interlong Bio-Technique Co Ltd is engaged in the research and development, manufacturing, and selling of medicines and medical devices. It is also involved in the purchase and sale of medicines and healthcare food products. The group's revenue and results from operations are mainly derived from activities in the PRC. The operating segments of the company are the Manufacturing and selling of medicines and medical devices; and the Sales and distribution of medicines, healthcare products, and medical devices.. The majority of revenue is generated from the Manufacturing and selling of medicines and medical devices segment.

Shenzhen Neptunus Interlong Bio-Technique Co Headlines

No Headlines